This trial studies the effect of AMG 510 in treating patients with KRAS G12C mutated non-squamous non-small cell lung cancer.
1 Primary · 4 Secondary · Reporting Duration: Up to 3 years
Experimental Treatment
116 Total Participants · 1 Treatment Group
Primary Treatment: Sotorasib · No Placebo Group · Phase 2
Age 18+ · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: